David Toung
Stock Analyst at Argus Research
(4.14)
# 468
Out of 5,149 analysts
132
Total ratings
63.73%
Success rate
9.56%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Upgrades: Buy | $35 | $26.58 | +31.68% | 2 | Mar 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $541.80 | +3.36% | 3 | Feb 6, 2026 | |
| HOLX Hologic | Downgrades: Hold | n/a | $75.46 | - | 3 | Jan 12, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $56.99 | +19.32% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $508.10 | +20.06% | 8 | Oct 29, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $96.71 | +18.91% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $181.58 | +55.30% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $284.03 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $47.22 | +10.12% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $289.21 | - | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $10.56 | - | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $233.86 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $226.35 | -44.78% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $175.69 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $377.00 | -9.81% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $995.69 | -32.71% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $97.97 | +53.11% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,007.73 | -16.64% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $78.13 | +40.79% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $282.99 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $384.59 | -19.39% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $497.42 | -35.67% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $113.61 | +18.83% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $147.83 | -49.27% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $61.22 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $119.83 | -8.20% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.10 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $201.76 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $164.18 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $246.75 | -37.18% | 4 | Mar 27, 2020 |
Pfizer
Mar 2, 2026
Upgrades: Buy
Price Target: $35
Current: $26.58
Upside: +31.68%
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $541.80
Upside: +3.36%
Hologic
Jan 12, 2026
Downgrades: Hold
Price Target: n/a
Current: $75.46
Upside: -
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $56.99
Upside: +19.32%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $508.10
Upside: +20.06%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $96.71
Upside: +18.91%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $181.58
Upside: +55.30%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $284.03
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $47.22
Upside: +10.12%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $289.21
Upside: -
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $10.56
Upside: -
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $233.86
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $226.35
Upside: -44.78%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $175.69
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $377.00
Upside: -9.81%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $995.69
Upside: -32.71%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $97.97
Upside: +53.11%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,007.73
Upside: -16.64%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $78.13
Upside: +40.79%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $282.99
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $384.59
Upside: -19.39%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $497.42
Upside: -35.67%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $113.61
Upside: +18.83%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $147.83
Upside: -49.27%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $61.22
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $119.83
Upside: -8.20%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $5.10
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $201.76
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $164.18
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $246.75
Upside: -37.18%